University Hospital

Medicine & Life Sciences

1. Neoplasms 100%
2. Non-Small Cell Lung Carcinoma 83%
3. Japan 81%
4. Therapeutics 72%
5. Lung Neoplasms 54%
6. Lung 53%
7. Drug Therapy 52%
8. Mutation 44%
9. Breast Neoplasms 43%
10. Neoplasm Metastasis 43%
11. Recurrence 42%
12. Survival 42%
13. Kidney 39%
14. Tomography 37%
15. Serum 36%
16. Genes 36%
17. Lung Transplantation 35%
18. Hepatocellular Carcinoma 35%
19. ErbB Receptors 35%
20. Tibial Meniscus 34%
21. Cisplatin 33%
22. Bone and Bones 31%
23. Radiofrequency Ablation 31%
24. Living Donors 28%
25. Prostatic Neoplasms 27%
26. Liver 27%
27. Cell Line 27%
28. Transplants 27%
29. Small Cell Lung Carcinoma 26%
30. Liver Transplantation 26%
31. Gefitinib 25%
32. Magnetic Resonance Imaging 24%
33. Safety 24%
34. Stomach Neoplasms 24%
35. Biopsy 23%
36. Confidence Intervals 23%
37. Retrospective Studies 22%
38. Adenoviridae 21%
39. Prospective Studies 21%
40. Carcinoma 21%
41. Chemoradiotherapy 20%
42. Tooth 20%
43. Diabetic Nephropathies 20%
44. Radiotherapy 20%
45. Incidence 19%
46. Wounds and Injuries 19%
47. Pediatrics 19%
48. Apoptosis 19%
49. Lymph Nodes 19%
50. Cohort Studies 19%
51. Stroke 18%
52. Stomach 18%
53. Colorectal Neoplasms 18%
54. Proteins 18%
55. Hemorrhage 18%
56. Tears 18%
57. Progression-Free Survival 18%
58. Odds Ratio 17%
59. Child 17%
60. Multicenter Studies 17%
61. Seizures 17%
62. Elderly 17%
63. Brain 16%
64. Squamous Cell Carcinoma 16%
65. Stents 16%
66. Aneurysm 16%
67. Docetaxel 16%
68. Eye 16%
69. Tissue Donors 16%
70. Messenger RNA 16%
71. Periodontitis 16%
72. Biomarkers 16%
73. Protein-Tyrosine Kinases 15%
74. Atrial Heart Septal Defects 15%
75. Growth 15%
76. Esophageal Neoplasms 15%
77. Thorax 15%
78. Pharmaceutical Preparations 15%
79. Lymphoma 15%
80. Gene Expression 15%
81. Survival Rate 15%
82. Skin 14%
83. Cytokines 14%
84. In Vitro Techniques 14%
85. Knee 14%
86. Electroencephalography 14%
87. Hematopoietic Stem Cell Transplantation 14%
88. Randomized Controlled Trials 14%
89. Infections 14%
90. Injections 14%
91. Urinary Bladder Neoplasms 14%
92. Telomerase 14%
93. Endoscopic Mucosal Resection 14%
94. Oxidative Stress 14%
95. Adenocarcinoma of Lung 13%
96. Hepatectomy 13%
97. Antibodies 13%
98. Alzheimer Disease 13%
99. Inflammation 13%
100. Renal Cell Carcinoma 13%